Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cells

Ken Ichi Kozaki, Johji Inazawa

Research output: Contribution to journalReview articlepeer-review

38 Citations (Scopus)

Abstract

MicroRNA (miRNA) genes, located in intergenic or intragenic non-coding regions of the genome, are transcribed and processed to small non-protein-coding RNA of approximately 22 nucleotides negatively regulating gene expression. Some miRNA have already been reported for their genetic alterations, aberrant expression and oncogenic or tumor-suppressive functions. After 2008, there has been a striking increase in the number of publications reporting tumor-suppressive miRNA (TS-miRNA) silenced epigenetically in various types of cancers, suggesting important clinical applications for miRNA-based molecular diagnosis and therapy for cancers. Here, we introduce a correlation of the gene silencing of TS-miRNA through CpG island hypermethylation with the genomic distances between intergenic and intragenic miRNA genes or protein-coding host genes and CpG islands located around these genes. Furthermore, we also discuss the potential of miRNA replacement therapy for cancers using double-stranded RNA mimicking TS-miRNA.

Original languageEnglish
Pages (from-to)837-845
Number of pages9
JournalCancer Science
Volume103
Issue number5
DOIs
Publication statusPublished - May 2012

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cells'. Together they form a unique fingerprint.

Cite this